We use cookies in order to provide you with a user-friendly and effective service as well as content adapted to your interests. We also use cookies to dynamically display Univadis ads and ads from our business partners on both Univadis and selected third party websites. By clicking or navigating the site, you agree to this use.
Manage preferences. Learn more.

Univadis - a service form MSD

A trusted medical reference

Create an account Log in

app catalog Search

Log in

Close

My Account

Loading...

Medical News Medical Quiz Oncology Delete Conference Reports Link Library Delete Lausunto- ja lomakepohjat HCV Journals Delete HIV Delete HIV videos Explore new apps

See all my apps Hide my apps

Explore new apps Manage my apps

Rearrange your apps by dragging them or delete them with the cross.

Save Cancel

Welcome. Please log in or create an account.

Log in

Remember me (Uncheck if on a shared computer)

Forgot your password ?

Please review the fields marked in red and resubmit the form

Create an account

Register to access independent medical news and resources from Univadis^®

Latest updates

Medical News

Ebola’s existence in an animal reservoir predicts new outbreaks will occur

Ebola, measles and now COVID-19 hit the Democratic Republic of the Congo

Univadis Medical News
03 June 2020

Ebola’s existence in an animal reservoir predicts new outbreaks will occur

Clinical practice guidelines required for testing and treating hypothyroidism in pregnancy

Over medication of hypothyroidism during pregnancy

Univadis Medical News
03 June 2020

Clinical practice guidelines required for testing and treating hypothyroidism in pregnancy

The increased risk continued for 12 weeks after treatment.

SSRIs linked to increased risk of committing violent crimes

Univadis Medical News
03 June 2020

The increased risk continued for 12 weeks after treatment.

Extent of the impact of health disruptions will be unknown for some time.

COVID-19 significantly impacting health services for noncommunicable diseases

Univadis Medical News
02 June 2020

Extent of the impact of health disruptions will be unknown for some time.

First we were seen as heroes, then the attitude changed, lead author says.

Death threats against authors of chloroquine trial

Univadis Medical News
02 June 2020

First we were seen as heroes, then the attitude changed, lead author says.

More Medical News >

Conference Reports

ASCO 2020 – Metastatic NSCLC: no clear benefit with chemo add-on to durvalumab+tremelimumab

Oncology Conference reports
03 June 2020

Addition of platinum-based regimen yielded no OS improvement.

ASCO 2020 – New regimen yields better adherence, less toxicity in head and neck SCC

Oncology Conference reports
03 June 2020

First hints of noninferiority for chemoradiotherapy weekly vs q3w in high-risk, post-op patients.

ASCO 2020 – Osimertinib improves DFS after surgery for localized NSCLC

Oncology Conference reports
03 June 2020

Phase 3 ADAURA trial results offer additional treatment options for stage II-IIIA disease.

More Conference Reports >

Featured channels

application icon

HIV All you need to know about HIV

application icon

Oncology Oncology essentials all in one place

application icon

Zika All you need to know about Zika virus

About Univadis^®

Univadis^® provided by Aptus Health, brings you unbiased, relevant medical news as well as helpful resources for your daily practice at no cost.

Our Partners

Univadis^® brings together premium content publishers that deliver comprehensive and up-to-date medical information.

Contact Us

E-mail Us

Complete contact form >

Aptus Health does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Aptus Health sources. Please read our Terms of Use for more information

Terms of Use | Privacy Policy

©2020 Aptus Health, Inc. All rights reserved.